Science Explorer Back to mapMap
Discussion
Researcher · Okayama Medical Center · Japan

Toshiro Yonei

Toshiro Yonei publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Neurology, on topics such as Lung Cancer Treatments and Mutations, Lung Cancer Research Studies and Lung Cancer Diagnosis and Treatment.

OpenAlex
World rank
#2,665,012
of 7,710,434 ranked researchers
Rank in Japan
#55,738
of 383,136
Works
34
Citations
1.1k
Citations per work
31.2
h-index
12
i10-index 12Top 42% in Pulmonary and Respiratory Medicine
Toshiro Yonei

What does Toshiro Yonei research?

Toshiro Yonei's work is mostly in Medicine (78%), Biochemistry, Genetics and Molecular Biology (4%).

Health Sciences: 26 works · 77.5% of their workMedicine: 26 works · 77.5% of their workPulmonary and Respiratory Medicine: 12 works · 36.7% of their workOncology: 8 works · 24.5% of their workNeurology: 2 works · 7.1% of their workSurgery: 2 works · 6.1% of their workCardiology and Cardiovascular Medicine: 1 works · 3.1% of their workEverything else: 6 works · 18.4% of their workLife Sciences: 1 works · 4.1% of their workBiochemistry, Genetics and Molecular Biology: 1 works · 4.1% of their workMolecular Biology: 1 works · 4.1% of their workTHEIR WORKToshiro Yonei34works
Life Sciences4%Health Sciences78%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine2677.5%
  2. Everything else618.4%
    1. Biochemistry, Genetics and Molecular Biology14.1%
  1. 1Pulmonary and Respiratory Medicine37% of their works
  2. 2Oncology24% of their works
  3. 3Neurology7% of their works
  4. 4Surgery6% of their works
  5. 5Molecular Biology4% of their works
  6. 6Cardiology and Cardiovascular Medicine3% of their works

Research topics

Which keywords describe Toshiro Yonei's research?

The keywords of their largest research topics: Clinical Trials, Targeted Therapy, Chemotherapy, Immunotherapy, Metastasis, ALK Inhibitors, EGFR Mutations and Genomic Profiles.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 21 words, with their numbers
  1. Clinical Trials252 topics
  2. Targeted Therapy252 topics
  3. Chemotherapy213 topics
  4. Immunotherapy152 topics
  5. Metastasis152 topics
  6. ALK Inhibitors131 topic
  7. EGFR Mutations131 topic
  8. Genomic Profiles121 topic
  9. Small-Cell Lung Cancer121 topic
  10. CT Screening61 topic
  11. Lung Cancer61 topic
  12. Pulmonary Alveolar Microlithiasis41 topic
  13. Pulmonary Sclerosing Hemangioma41 topic
  14. Cancer of Unknown Primary31 topic
  15. Chemotherapy-Induced Peripheral Neuropathy31 topic
  16. DNA31 topic
  17. Myasthenia Gravis31 topic
  18. Taxanes31 topic
  19. Thymic Tumors31 topic
  20. Tissue of Origin31 topic
  21. Topoisomerases31 topic

Where does Toshiro Yonei work?

Toshiro Yonei's main affiliation in the publication record is Okayama Medical Center, Japan.

How many publications and citations does Toshiro Yonei have?

OpenAlex counts 34 works and 1,061 citations for Toshiro Yonei, an h-index of 12, ranking #2,665,012 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Toshiro Yonei. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.